For the second time this week, Attorney General Paxton and a bipartisan group of attorneys general announced an agreement in principle to address the opioid crisis
Opioids Maker Teva Agrees to $4.25 billion settlement: Preliminary Agreement Will Provide Cash and Naloxone to Address Opioids Crisis
Attorney General Paxton has reached an agreement on key financial terms with opioid maker Teva, which would provide up to $4.25 billion to participating states and local governments.
AG Paxton Launches Investigation Into Walmart for Potentially Deceiving Texans About Opioids
Today Attorney General Ken Paxton issued a Civil Investigative Demand (CID) to Walmart for potential violations of the Texas Deceptive Trade Practices Act (DTPA) relating to the promotion, sale, dispensing, and distribution of prescription opioids.
Attorney General Paxton successfully secured $1.167 billion for Texas out of the $26 billion opioid agreement with the nation’s three major pharmaceutical distributors – Cardinal, McKesson, and AmerisourceBergen.
Attorney General Paxton has reached an opioid settlement of $225 million with Teva Pharmaceutical Industries. General Paxton has fought for Texans who have been impacted by the improper marketing of opioids manufactured by the pharmaceutical companies, which have caused the tragic deaths of several thousand people every year.
Texas Attorney General Ken Paxton announced a $63 million statewide opioid settlement with Endo Pharmaceuticals, Inc. The agreement will largely track the terms of the Global Prescription Opioid Litigation Settlement Agreement that was announced on July 23, 2021.
Texas Attorney General Ken Paxton announced a $290 million statewide opioid settlement agreement with Johnson & Johnson to resolve opioid-related claims.
Following on his previous announcement, Attorney General Ken Paxton announced his intention to join the $21 billion opioid distributor settlement in a press conference on Thursday.
Attorney General Ken Paxton announced a historic $26 billion agreement that will bring desperately needed relief to Texans who are struggling with opioid addiction. The agreement includes Cardinal, McKesson, and AmerisourceBergen – the nation’s three major pharmaceutical distributors – and Johnson & Johnson, which manufactured and marketed opioids.
Purdue Pharma Files Bankruptcy Plan, Establishing Trust for Nationwide Opioid Abatement Efforts
Texas Attorney General Ken Paxton today announced that Purdue Pharma filed its estimated $7 billion bankruptcy plan, which places the value of the company into a trust set up to allocate funds toward opioid abatement efforts across the nation.